Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - KING PHARMACEUTICALS INC | g22905e10vq.htm |
| EX-31.1 - EX-31.1 - KING PHARMACEUTICALS INC | g22905exv31w1.htm |
| EX-32.1 - EX-32.1 - KING PHARMACEUTICALS INC | g22905exv32w1.htm |
| EX-31.2 - EX-31.2 - KING PHARMACEUTICALS INC | g22905exv31w2.htm |
| EX-10.5 - EX-10.5 - KING PHARMACEUTICALS INC | g22905exv10w5.htm |
EXHIBIT 32.2
CERTIFICATION
OF CHIEF FINANCIAL OFFICER
PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002
PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002
In connection with this quarterly report on
Form 10-Q
of King Pharmaceuticals, Inc. I, Joseph Squicciarino, Chief
Financial Officer of King Pharmaceuticals, Inc., certify,
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that:
1. The report fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of
1934; and
2. The information contained in this report fairly
presents, in all material respects, the financial condition and
results of operations of King Pharmaceuticals, Inc.
/s/ JOSEPH
SQUICCIARINO
Joseph Squicciarino
Chief Financial Officer
Date: May 5, 2010